[RGLS] YoY Quarter Result on 31-Mar-2012 [#Q1]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
30-Mar-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- -11.51%
YoY-
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Revenue 18 18 489 4,200 1,631 3,238 3,344 -58.11%
PBT -16,024 -20,025 -21,212 -14,491 -12,740 -7,239 -2,246 38.72%
Tax 1 -4 -5 -4 1 -10 1 0.00%
NP -16,025 -20,021 -21,207 -14,487 -12,741 -7,229 -2,247 38.71%
Tax Rate - - - - - - - -
Total Cost 16,043 20,039 21,696 18,687 14,372 10,467 5,591 19.19%
Ratio Analysis
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
NP Margin -89,027.78 -111,227.78 -4,336.81 -344.93 -781.18 -223.26 -67.19 231.23%
Per Share
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
EPS -18.49 -45.34 -48.28 -34.72 -35.81 -24.18 -1,568.04 -52.27%
EPS Diluted -18.49 -45.34 -48.28 -34.72 -35.81 -24.18 -1,568.04 -52.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.